NCT05998135 2025-09-11Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian CancerEmory UniversityPhase 2 Recruiting28 enrolled
NCT06266091 2025-07-20Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific AntibodyWuhan YZY Biopharma Co., Ltd.Phase 2 Completed115 enrolled